Carcinosarcoma of the ovary a review.
Carcinosarcoma of the ovary, also referred to as mixed mullerian tumor of the ovary, is a rare and aggressive tumor. This tumor type is unique in that it contains malignant epithelial and stromal elements. The average survival for a woman diagnosed with carcinosarcoma of the ovary is less than 2 years. Due to the rarity of this tumor, the optimal treatment for carcinosarcoma of the ovary has not been determined. We review the pathology, risk factors, and current treatment recommendations for carcinosarcoma of the ovary.
Cantrell
Leigh A
LA
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, NC 27599, USA.
Van Le
Linda
L
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood; D002296:Carcinosarcoma / Q000097:blood / Q000235:genetics / Q000473:pathology* / Q000628:therapy*; D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood / Q000235:genetics / Q000473:pathology / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood / Q000235:genetics / Q000473:pathology* / Q000628:therapy*; D011379:Prognosis; D012307:Risk Factors; D055815:Young Adult
D014408:Biomarkers, Tumor